Fluoroquinolones: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "* " to "*") |
No edit summary |
||
| Line 7: | Line 7: | ||
==Adverse Effects== | ==Adverse Effects== | ||
*Common adverse effects | |||
**GI and neuro toxicity | |||
**Rash | |||
**QT prolongation | |||
**Hyper/hypoglycemia | |||
**Hematologic toxicity | |||
*Black box warning from US FDA | *Black box warning from US FDA | ||
*Tendon Rupture & Tendinitis <ref>Gültuna S. et al. Ciprofloxacin induced tendinitis. J Clin Rheumatol. 2009;15 (4): 201-2</ref> | |||
*Peripheral Neuropathy<ref>Food and Drug Administration: Drug safety announcement about fluoroquinolones and possible peripheral neuropathy [http://www.fda.gov/downloads/Drugs/DrugSafety/UCM365078.pdf PDF]</ref> | |||
{{Template:Clinically Utilized Antibiotics}} | {{Template:Clinically Utilized Antibiotics}} | ||
==See Also== | ==See Also== | ||
Revision as of 02:58, 1 November 2016
Indications
- UTI (2nd line)
- Prostatitis
- Chlamydia
- PID
- Traveler's Diarrhea
Adverse Effects
- Common adverse effects
- GI and neuro toxicity
- Rash
- QT prolongation
- Hyper/hypoglycemia
- Hematologic toxicity
- Black box warning from US FDA
- Tendon Rupture & Tendinitis [1]
- Peripheral Neuropathy[2]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
See Also
References
- Goodman & Gilman's Pharmacology
- FDA info for Health Professionals